Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Feces metagenome

ABSTRACT: Klebsiella pneumoniae isolated from patients with primary sclerosing cholangitis

PROVIDER: PRJDB7573 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	DRR154710_1.fastq.gz	Fastqsanger.gz
	DRR154710_2.fastq.gz	Fastqsanger.gz
	DRR154711_1.fastq.gz	Fastqsanger.gz
	DRR154711_2.fastq.gz	Fastqsanger.gz
	DRR154712_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 170

Similar Datasets

Klebsiella pneumoniae

Project description:Klebsiella pneumoniae isolated from patients with primary sclerosing cholangitis

| PRJDB7545 | ENA

Common functional alterations identified in blood transcriptome of autoimmune cholestatic liver and inflammatory bowel diseases

Project description:Primary biliary cholangitis (PBC), primary sclerosing cholangitis (PSC), and inflammatory bowel diseases (IBDs), including Crohn’s disease (CD) and ulcerative colitis (UC), are heterogeneous chronic autoimmune diseases that may share underlying pathogenic mechanisms. Herein, we compared simultaneously analyzed blood transcriptomes from patients with PBC, PSC, and IBD.

2019-05-01 | GSE119600 | GEO

RNAseq data from human colon organoid infected by KP

Project description:The aim of this study is to identify the specific bacteria that are responsible for pathological bacterial translocation and subsequent Th17 priming in the liver in primary sclerosing cholangitis (PSC). To clarify the mechanism of how microbiota interacts with the intestinal epithelial barrier, monolayered human intestinal organoids were cultured with the specific bacteria. Gene expression analysis using RNA sequencing in epithelial cells cultured with Klebsiella pneumoniae derived from a PSC patient (KP-P1) or commercially obtained Klebsiella pneumoniae strain (KP JCM1662) was performed in this study.

| EGAS00001003332 | EGA

mouse gut metagenome

Project description:Bacteriophage therapy against pathological Klebsiella pneumoniae that determine the clinical course of primary sclerosing cholangitis

| PRJDB15127 | ENA

Project description:Dietary intervention on Primary Sclerosing Cholangitis

| PRJNA1108337 | ENA

Project description:Bacteriophage therapy against pathological Klebsiella pneumoniae that determine the clinical course of primary sclerosing cholangitis

| PRJNA887913 | ENA

Acyl Carnitines Concentrations of Primary Sclerosing Cholangitis (part III)

Project description:To qualitatively and quantitatively analyze enterohepatically-circulated molecules using targeted acyl carnitines concentrations of peripheral blood collected from primary sclerosing cholangitis (PSC) patients compared to normal and diseased controls. There are three groups of patients. (1) Normal donor controls (ND), (2) Patients with Primary Sclerosing Cholangitis (PSC), and (3) Disease Controls (DC) which are patients with liver disease other than PSC.

2017-07-05 | ST000997 | MetabolomicsWorkbench

Bile Acid of Primary Sclerosing Cholangitis (part IV)

Project description:To qualitatively and quantitatively analyze enterohepatically-circulated molecules using targeted bile acid concentrations of peripheral blood collected from primary sclerosing cholangitis (PSC) patients compared to normal and diseased controls. There are three groups of patients. (1) Normal donor controls (ND), (2) Patients with Primary Sclerosing Cholangitis (PSC), and (3) Disease Controls (DC) which are patients with liver disease other than PSC.

2017-07-05 | ST000998 | MetabolomicsWorkbench

Non-Esterified Fatty Acids of Primary Sclerosing Cholangitis (part II)

Project description:To qualitatively and quantitatively analyze enterohepatically-circulated molecules using targeted free fatty acid concentrations of peripheral blood collected from primary sclerosing cholangitis (PSC) patients compared to normal and diseased controls. There are three groups of patients. (1) Normal donor controls (ND), (2) Patients with Primary Sclerosing Cholangitis (PSC), and (3) Disease Controls (DC) which are patients with liver disease other than PSC.

2017-07-05 | ST000996 | MetabolomicsWorkbench

Amino Acid Concentrations of Primary Sclerosing Cholangitis (part I)

Project description:To qualitatively and quantitatively analyze enterohepatically-circulated molecules using targeted amino acid concentrations of peripheral blood collected from primary sclerosing cholangitis (PSC) patients compared to normal and diseased controls. There are three groups of patients. (1) Normal donor controls (ND), (2) Patients with Primary Sclerosing Cholangitis (PSC), and (3) Disease Controls (DC) which are patients with liver disease other than PSC.

2018-07-05 | ST000995 | MetabolomicsWorkbench

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data